Lv4
518 积分 2024-06-06 加入
Bridging Studies in Preclinical Pharmaceutical Safety Assessment
1个月前
已关闭
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes
1个月前
已完结
Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins
1个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
3个月前
已完结
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial
3个月前
已完结
The Gut-Bone Axis in Diabetes
3个月前
已完结
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
4个月前
已完结
Binding sites and design strategies for small molecule GLP-1R Agonists
4个月前
已完结
Peptide and peptide-based drugs
5个月前
已完结
皖公网安备34019202002308
